Pamela Hull joins Markey as associate director of population science and community impact

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Medical sociologist Pamela Hull was named associate director of population science and community impact at the University of Kentucky Markey Cancer Center

She will also serve as the William Stamps Farish Endowed Chair in Cancer Research and join the UK College of Medicine as an associate professor of behavioral science.

Hull’s expertise is in the development, testing and dissemination of behavioral interventions to promote cancer prevention behaviors, and she has more than 15 years of experience conducting community-engaged research. She specializes in HPV-mediated cancer prevention, childhood obesity prevention, community-engaged research, and health disparities.

In her role as associate director, Hull will oversee Markey’s community outreach and engagement functions in addition to its population science research agenda and infrastructure, which includes Markey’s Cancer Prevention and Control Research Program. She will also have oversight of the Kentucky Cancer Program-East and the Kentucky Cancer Consortium. The goal of Markey’s community outreach and engagement efforts is to accelerate science-to-practice translation across the cancer care continuum, with an emphasis on the needs of Kentucky’s citizens.

Two of Hull’s extramurally funded grants will also move to the UK. The first is a grant from NCI focused on increasing HPV vaccination in community-based pediatric practices. The second is a grant from the U.S. Department of Agriculture funding the development and testing of a smartphone application featuring shopping tools and nutrition education tools intended for use by low-income and nutritionally at-risk families and their children.

Prior to joining the UK Markey Cancer Center, Hull was an associate professor in the Vanderbilt University School of Medicine’s Division of Epidemiology and served as associate director of community outreach and engagement for the Vanderbilt-Ingram Cancer Center in Nashville. During her tenure at Vanderbilt, she led many community-engagement activities that helped reduce the cancer burden and health disparities with partners in the region.

Table of Contents

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login